Companies /Healthcare

Dyne Therapeutics Inc

NASDAQ: DYN Biotechnology
$26.09
▼ $0.28 (−1.04%) today
Markets open · 3:16pm ET
Today · % change

Fundamentals

Market Cap
$4.9B
EPS (TTM)
$-3.26
52-Week Range
$12 – $27
Street Target
$39.40

About Dyne Therapeutics

Dyne Therapeutics Inc is a pioneering biotech firm based in Waltham, Massachusetts, dedicated to developing innovative treatments for a range of genetically driven muscle diseases. With a focus on conditions like myotonic dystrophy type 1, duchenne muscular dystrophy, and facioscapulohumeral dystrophy, the company leverages its proprietary FORCE platform to create therapeutics aimed at modifying the course of these diseases. Founded in 2017, Dyne Therapeutics is at the forefront of addressing unmet needs in muscle disease treatment.

DYN Coverage